cbdMD Successfully Launches Into a Growing Japanese Market

Charlotte, North Carolina--(Newsfile Corp. - November 29, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized health and wellness companies, has announced it has completed a successful initial launch into the emerging Japanese market.

According to Brightfield Group, a leading CBD research firm, Japan is the largest CBD market by revenue in the Asia Pacific and Middle East region. cbdMD believes Japan is poised to become one of the next big international CBD markets, with a cultural emphasis on natural health solutions and one of the largest consumer health economies in the world. A year in the making, cbdMD is wrapping up its third strong month of sales of its Japanese specific portfolio of products launched under the cbdMD Pro line. Products will be sold to end consumers through our Japanese website. This marks further expansion into international markets, coming off recent developments in the EU and UK as the Company was one of the first to earn Validation from the Food Safety Authority.

"We're looking forward to serving the Japanese public and making our cbdMD portfolio of wellness products available to be added as part of their daily routine and lifestyle," said President of cbdMD, Inc., Kevin MacDermott. "In regard to CBD, the health conscious Japanese consumer still represents an underserved market. We believe that by offering cbdMD's high-quality products we will be able to attract a whole new group of consumers looking for natural alternatives. We are seeing strong interest from both the elderly and working population who are looking for natural remedies to everyday issues, including occasional pain and discomfort. This expansion marks the next phase of international growth as we look to continue bringing our globally recognized brand to new emerging markets."

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified using words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements, including but not limited to expectations on our clinical studies, and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2021 as filed with the Securities and Exchange Commission (the "SEC") on December 17, 2021 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

1 THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CFO
+1 (704) 445-3064
[email protected]

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/146084

Original Source of the original story >> cbdMD Successfully Launches Into a Growing Japanese Market